JP2015532923A5 - - Google Patents

Download PDF

Info

Publication number
JP2015532923A5
JP2015532923A5 JP2015533048A JP2015533048A JP2015532923A5 JP 2015532923 A5 JP2015532923 A5 JP 2015532923A5 JP 2015533048 A JP2015533048 A JP 2015533048A JP 2015533048 A JP2015533048 A JP 2015533048A JP 2015532923 A5 JP2015532923 A5 JP 2015532923A5
Authority
JP
Japan
Prior art keywords
composition
tissue
antibiotic
ecm
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015533048A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015532923A (ja
Filing date
Publication date
Priority claimed from US13/573,569 external-priority patent/US9072816B2/en
Application filed filed Critical
Publication of JP2015532923A publication Critical patent/JP2015532923A/ja
Publication of JP2015532923A5 publication Critical patent/JP2015532923A5/ja
Pending legal-status Critical Current

Links

JP2015533048A 2012-09-24 2013-06-15 生体組織の治療のための方法及びシステム Pending JP2015532923A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/573,569 2012-09-24
US13/573,569 US9072816B2 (en) 2006-01-18 2012-09-24 Composition for modulating inflammation of cardiovascular tissue
PCT/US2013/046039 WO2014046752A1 (en) 2012-09-24 2013-06-15 Method and system for treatment of biological tissue

Publications (2)

Publication Number Publication Date
JP2015532923A JP2015532923A (ja) 2015-11-16
JP2015532923A5 true JP2015532923A5 (https=) 2016-07-28

Family

ID=50342519

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015533045A Pending JP2015532922A (ja) 2012-09-24 2013-05-29 生体組織の治療のための方法及びシステム
JP2015533049A Pending JP2015531664A (ja) 2012-09-24 2013-06-14 生体組織の治療のための方法及びシステム
JP2015533048A Pending JP2015532923A (ja) 2012-09-24 2013-06-15 生体組織の治療のための方法及びシステム

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2015533045A Pending JP2015532922A (ja) 2012-09-24 2013-05-29 生体組織の治療のための方法及びシステム
JP2015533049A Pending JP2015531664A (ja) 2012-09-24 2013-06-14 生体組織の治療のための方法及びシステム

Country Status (11)

Country Link
US (3) US9072816B2 (https=)
EP (3) EP2887948A4 (https=)
JP (3) JP2015532922A (https=)
CN (1) CN104703614A (https=)
AU (3) AU2013318632A1 (https=)
BR (2) BR112014031796A2 (https=)
CA (3) CA2875302A1 (https=)
IL (2) IL236021A0 (https=)
IN (1) IN2015DN01780A (https=)
SG (2) SG11201408808WA (https=)
WO (3) WO2014046744A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9283302B2 (en) 2011-12-16 2016-03-15 Cormatrix Cardiovascular, Inc. Extracellular matrix encasement structures and methods
US20080279833A1 (en) 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
US20220023503A9 (en) 2007-05-10 2022-01-27 Aziyo Med, Llc Extracellular Matrix Tissue Prostheses
BRPI1008628A2 (pt) * 2009-02-18 2016-03-01 Cormatrix Cardiovascular Inc método de tratamento ou prevenção de arritmia cardíaca em um indivíduo
EP3888714B8 (en) 2010-07-31 2025-05-21 Cook Biotech Incorporated Collagenous tissue pocket for an implantable medical device, and manufacturing method therefor
JP6110578B2 (ja) * 2014-11-10 2017-04-05 学校法人大阪医科薬科大学 幹細胞機能増強用スタチン封入ナノ粒子製剤、並びにそれを含有する機能増強幹細胞及びその製造方法
US20160143738A1 (en) * 2014-11-26 2016-05-26 Cormatrix Cardiovascular, Inc. Biological Constructs for Treating Damaged Organs and Tissue
US20160143720A1 (en) * 2014-11-26 2016-05-26 Cormatrix Cardiovascular, Inc. Mesh Fiber Members and Methods for Forming and Using Same for Treating Damaged Biological Tissue
WO2016093863A1 (en) * 2014-12-10 2016-06-16 Cormatrix Cardiovascular, Inc. Method and system for treatment of damaged biological tissue
KR20180015187A (ko) * 2015-06-03 2018-02-12 위스콘신 얼럼나이 리서어치 화운데이션 심장 섬유모세포-유래된 세포외 기질 및 허혈성 질환 또는 손상의 치료를 위한 이의 주사 가능한 제형
WO2017189986A1 (en) * 2016-04-28 2017-11-02 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compositions comprising extracellular matrix of primitive animal species and related methods
WO2018013361A1 (en) 2016-07-11 2018-01-18 Cormatrix Cardiovascular, Inc. Prosthetic tissue valves
KR101710615B1 (ko) * 2016-09-07 2017-02-27 주식회사 파마리서치프로덕트 생착률을 증가시킨 이식용 진피층 및 이의 제조 방법
EP3768337A1 (en) * 2018-03-22 2021-01-27 Queen Mary University of London Implantable cell dressing for treatment of disease
KR102235141B1 (ko) * 2018-06-19 2021-04-05 푸와이 하스피틀, 차이니즈 아카데미 오브 메디컬 사이언시즈 앤드 페킹 유니언 메디컬 칼리지 약물 전처리에 기초한 간엽 줄기세포 유래 엑소좀 제조방법
EP4196186A4 (en) 2020-08-17 2024-10-09 Elutia Med LLC DEPOSITS AND ENCAPSULATION STRUCTURES FOR IMPLANTABLE DEVICES

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US6485723B1 (en) * 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
US6096347A (en) * 1996-11-05 2000-08-01 Purdue Research Foundation Myocardial graft constructs
AU732726B2 (en) * 1996-12-10 2001-04-26 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
US6375989B1 (en) * 1996-12-10 2002-04-23 Purdue Research Foundation Submucosa extracts
IL139708A0 (en) * 2000-11-15 2002-02-10 Amiel Gilad Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
AU2002316694B2 (en) * 2001-07-16 2007-09-06 Depuy Products, Inc. Hybrid biologic/synthetic porous extracellular matrix scaffolds
US20040078090A1 (en) * 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
US20040175366A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
CA2529367C (en) * 2003-06-18 2012-09-11 Institut De Cardiologie De Montreal/Montreal Heart Institute Preventing atrial fibrillation (af) with the use of statin drugs
AU2004253508A1 (en) * 2003-06-25 2005-01-13 Acell, Inc. Conditioned matrix compositions for tissue restoration
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
FI20045223A7 (fi) * 2004-06-15 2005-12-16 Bioretec Oy Monitoiminen biohajoava komposiitti ja kirurginen implantti, joka käsittää mainitun komposiitin
CA2536923C (en) * 2003-09-04 2012-10-09 Cook Biotech Incorporated Extracellular matrix composite materials, and manufacture and use thereof
US8454678B2 (en) * 2005-03-19 2013-06-04 Cook Biotech Incorporated Prosthetic implants including ECM composite material
US20060293760A1 (en) * 2005-06-24 2006-12-28 Dedeyne Patrick G Soft tissue implants with improved interfaces
US8568761B2 (en) * 2005-07-15 2013-10-29 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent myocardium
US9532943B2 (en) * 2010-12-20 2017-01-03 Cormatrix Cardiovascular, Inc. Drug eluting patch for the treatment of localized tissue disease or defect
WO2008021127A2 (en) * 2006-08-08 2008-02-21 Howmedica Osteonics Corp. Expandable cartilage implant
WO2008109407A2 (en) * 2007-03-02 2008-09-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Extracellular matrix-derived gels and related methods
US11890371B2 (en) * 2007-12-26 2024-02-06 Petvivo Holdings, Inc. Biocompatible protein-based particles and methods thereof
WO2009086499A2 (en) 2007-12-28 2009-07-09 Cook Biotech Incorporated Medical composition including an extracellular matrix particulate
JP2010059235A (ja) * 2008-09-01 2010-03-18 Fujifilm Corp 紫外線吸収剤組成物
EP3246038B1 (en) * 2008-09-30 2021-04-07 The Regents of the University of California Compositions comprising decellularized extracellular matrix obtained from cardiac tissue
BRPI1008628A2 (pt) * 2009-02-18 2016-03-01 Cormatrix Cardiovascular Inc método de tratamento ou prevenção de arritmia cardíaca em um indivíduo

Similar Documents

Publication Publication Date Title
JP2015532923A5 (https=)
JP2011256183A5 (https=)
CL2009000426A1 (es) Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
CL2014000468A1 (es) Compuestos derivados del acido 2-oxo-6-(fenil/heteroaril)l-1,2-dihidropiridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para el alivio de una infeccion bacteriana.
WO2015024010A3 (en) Substituted hydroxamic acid compounds
JP2015129190A5 (https=)
BR112013015796A2 (pt) composição de agente de formação de imagem, método de preparar uma composição de agente de formação de imagem, método de preparar um quelante 18f-nota, e, composição farmacêutica.
CL2012003722A1 (es) Compuestos derivados del acido naf-2-ilacetico; composicion farmaceutica; y uso para el tratamiento del sida.
WO2013122888A3 (en) Methods of treating bacterial infections
BR112014030649A2 (pt) inibidores macrocíclicos da flaviviridae vírus
BR112013015010A2 (pt) produto, substrato, composição farmacêutica, uso de um produto, e, método para tratar uma infecção microbiana
EP2662353A3 (en) Antibacterial agents
JP2015504870A5 (https=)
ZA201105290B (en) Antibiotic compositions for the treatment of gram negative infections
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
FR21C1049I2 (fr) Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
DK3432900T3 (da) Mælkesyrebakteriesammensæting til behandling af bakterielle vaginale infektioner forårsaget af gardnerella vaginalis og, hvis de forefindes, samtidige svampeinfektioner
EP2217211A4 (en) ORAL ABSORBENT SOLID DOSAGE FORMULATION FOR VANCOMYCIN
CL2014000819A1 (es) Compuestos heterociclicos derivados de etinilo, moduladores alostericos mglur5; proceso de preparacion; composicion farmaceutica; uso en la prevencion o el tratamiento de esquizofrenia, enfermedades cognitivas, sindrome de la x fragil o autismo.
CL2014001154A1 (es) Compuestos derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo de formula i; composicion farmaceutica; uso para la prevencion o tratamiento de una infeccion bacteriana.
BRPI0923567A2 (pt) agentes antibactericidas novos para o tratamento de infecções gram positivas
DOP2010000373A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
CL2008000110A1 (es) Uso de compuestos derivados de piranona sustituidos para el tratamiento del sindrome metabolico; y compuestos derivados de piranona sustituidos.
LT3820856T (lt) C-manozido junginiai, naudingi šlapimo takų infekcijoms gydyti